Tamiflu 75 MG capsule 10S
Ended Awarded Last action
- Contract number
- SPE2D326F2218
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,387
Award facts
- Contract value 100% obligated
- $1,387.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,387.32 firm fixed-price delivery order to Genentech USA, Inc. for 10 capsules of Tamiflu 75 mg on December 8, 2025, with completion expected by December 11, 2025. Tamiflu (oseltamivir) is an antiviral medication used for influenza treatment and prevention, critical to federal healthcare and emergency preparedness operations. The award was issued without a set-aside designation, indicating open competition for this pharmaceutical supply contract. Genentech USA, Inc., a South San Francisco-based biotechnology and pharmaceutical manufacturer, specializes in providing essential medications to federal agencies and maintains SAM.gov registration since 2008.
This delivery order is supported by Genentech's substantial $27.9 million indefinite delivery contract with DLA Troop Support Medical, which runs through May 2031 and enables flexible procurement of medical supplies with pre-established pricing. The company also maintains a $4.9 billion Federal Supply Schedule contract with the Department of Veterans Affairs for drugs and pharmaceuticals through September 2028, positioning it as a critical supplier to the federal government's medical supply chain. These contract vehicles operate under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), allowing federal agencies to efficiently procure time-sensitive medications and treatments to support national stockpiles and ongoing healthcare requirements.
Quick answers
Who was awarded contract SPE2D326F2218?
SPE2D326F2218 was awarded to Genentech Usa, Inc. by Medical Supply Chain (Troop Support) on December 8, 2025.
How much is contract SPE2D326F2218 worth?
The government has obligated $1,387 on SPE2D326F2218.
Is contract SPE2D326F2218 an order under another contract?
Yes. SPE2D326F2218 is a delivery order under SPE2D021D0005, an indefinite delivery contract.
Was contract SPE2D326F2218 competed?
The extent of competition for SPE2D326F2218 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award